Insulin pump therapy in the perioperative period: A review of care after implementation of institutional guidelines

Mary E. Boyle, Karen M. Seifert, Karen A. Beer, Patricia Mackey, Richard T. Schlinkert, Joshua D. Stearns, Curtiss B. Cook

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background: An institutional policy was previously established for patients with diabetes on insulin pump therapy undergoing elective surgical procedures. Method: Electronic medical records were reviewed to assess documentation of insulin pump status and glucose monitoring during preoperative, intraoperative, and postanesthesia care unit (PACU) phases of care. Results: Twenty patients with insulin pumps underwent 23 procedures from March 1 to December 31, 2011. Mean (standard deviation) age was 58 (13) years, mean diabetes duration was 28 (17) years, and mean duration of insulin pump therapy was 7 (6) years. Nearly all cases (86%) during the preoperative phase had the presence of the device documented-an improvement over the 64% noted in data collected before the policy. Intraoperatively, 13 cases (61%) had the presence of the pump documented, which was higher than the 28% before implementation of the policy. However, documentation of pump status was found in only 38% in the PACU and was actually less than the 60% documented previously. Over 90% of cases had glucose checked in the preoperative area and the PACU, and only 60% had it checked intraoperatively, which was nearly identical to the percentages seen before policy implementation. No adverse events occurred when insulin pump therapy was continued. Conclusions: Although some processes still require improvement, preliminary data suggest that the policy for perioperative management of insulin pumps has provided useful structure for care of these cases. The data thus far indicate that insulin pump therapy can be continued safely during the perioperative period.

Original languageEnglish (US)
Pages (from-to)1016-1021
Number of pages6
JournalJournal of diabetes science and technology
Volume6
Issue number5
DOIs
StatePublished - 2012

Fingerprint

Perioperative Period
Insulin
Pumps
Guidelines
Documentation
Therapeutics
Medical problems
Intraoperative Care
Elective Surgical Procedures
Organizational Policy
Glucose
Electronic Health Records
Electronic medical equipment
Equipment and Supplies
Monitoring

Keywords

  • Continuous subcutaneous insulin infusion
  • Hospital
  • Inpatient
  • Insulin pumps
  • Perioperative
  • Surgery

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Bioengineering
  • Biomedical Engineering

Cite this

Boyle, M. E., Seifert, K. M., Beer, K. A., Mackey, P., Schlinkert, R. T., Stearns, J. D., & Cook, C. B. (2012). Insulin pump therapy in the perioperative period: A review of care after implementation of institutional guidelines. Journal of diabetes science and technology, 6(5), 1016-1021. https://doi.org/10.1177/193229681200600504

Insulin pump therapy in the perioperative period : A review of care after implementation of institutional guidelines. / Boyle, Mary E.; Seifert, Karen M.; Beer, Karen A.; Mackey, Patricia; Schlinkert, Richard T.; Stearns, Joshua D.; Cook, Curtiss B.

In: Journal of diabetes science and technology, Vol. 6, No. 5, 2012, p. 1016-1021.

Research output: Contribution to journalArticle

Boyle, Mary E. ; Seifert, Karen M. ; Beer, Karen A. ; Mackey, Patricia ; Schlinkert, Richard T. ; Stearns, Joshua D. ; Cook, Curtiss B. / Insulin pump therapy in the perioperative period : A review of care after implementation of institutional guidelines. In: Journal of diabetes science and technology. 2012 ; Vol. 6, No. 5. pp. 1016-1021.
@article{d94080f641f243efa069f8e309417f19,
title = "Insulin pump therapy in the perioperative period: A review of care after implementation of institutional guidelines",
abstract = "Background: An institutional policy was previously established for patients with diabetes on insulin pump therapy undergoing elective surgical procedures. Method: Electronic medical records were reviewed to assess documentation of insulin pump status and glucose monitoring during preoperative, intraoperative, and postanesthesia care unit (PACU) phases of care. Results: Twenty patients with insulin pumps underwent 23 procedures from March 1 to December 31, 2011. Mean (standard deviation) age was 58 (13) years, mean diabetes duration was 28 (17) years, and mean duration of insulin pump therapy was 7 (6) years. Nearly all cases (86{\%}) during the preoperative phase had the presence of the device documented-an improvement over the 64{\%} noted in data collected before the policy. Intraoperatively, 13 cases (61{\%}) had the presence of the pump documented, which was higher than the 28{\%} before implementation of the policy. However, documentation of pump status was found in only 38{\%} in the PACU and was actually less than the 60{\%} documented previously. Over 90{\%} of cases had glucose checked in the preoperative area and the PACU, and only 60{\%} had it checked intraoperatively, which was nearly identical to the percentages seen before policy implementation. No adverse events occurred when insulin pump therapy was continued. Conclusions: Although some processes still require improvement, preliminary data suggest that the policy for perioperative management of insulin pumps has provided useful structure for care of these cases. The data thus far indicate that insulin pump therapy can be continued safely during the perioperative period.",
keywords = "Continuous subcutaneous insulin infusion, Hospital, Inpatient, Insulin pumps, Perioperative, Surgery",
author = "Boyle, {Mary E.} and Seifert, {Karen M.} and Beer, {Karen A.} and Patricia Mackey and Schlinkert, {Richard T.} and Stearns, {Joshua D.} and Cook, {Curtiss B.}",
year = "2012",
doi = "10.1177/193229681200600504",
language = "English (US)",
volume = "6",
pages = "1016--1021",
journal = "Journal of diabetes science and technology",
issn = "1932-2968",
publisher = "Diabetes Technology Society",
number = "5",

}

TY - JOUR

T1 - Insulin pump therapy in the perioperative period

T2 - A review of care after implementation of institutional guidelines

AU - Boyle, Mary E.

AU - Seifert, Karen M.

AU - Beer, Karen A.

AU - Mackey, Patricia

AU - Schlinkert, Richard T.

AU - Stearns, Joshua D.

AU - Cook, Curtiss B.

PY - 2012

Y1 - 2012

N2 - Background: An institutional policy was previously established for patients with diabetes on insulin pump therapy undergoing elective surgical procedures. Method: Electronic medical records were reviewed to assess documentation of insulin pump status and glucose monitoring during preoperative, intraoperative, and postanesthesia care unit (PACU) phases of care. Results: Twenty patients with insulin pumps underwent 23 procedures from March 1 to December 31, 2011. Mean (standard deviation) age was 58 (13) years, mean diabetes duration was 28 (17) years, and mean duration of insulin pump therapy was 7 (6) years. Nearly all cases (86%) during the preoperative phase had the presence of the device documented-an improvement over the 64% noted in data collected before the policy. Intraoperatively, 13 cases (61%) had the presence of the pump documented, which was higher than the 28% before implementation of the policy. However, documentation of pump status was found in only 38% in the PACU and was actually less than the 60% documented previously. Over 90% of cases had glucose checked in the preoperative area and the PACU, and only 60% had it checked intraoperatively, which was nearly identical to the percentages seen before policy implementation. No adverse events occurred when insulin pump therapy was continued. Conclusions: Although some processes still require improvement, preliminary data suggest that the policy for perioperative management of insulin pumps has provided useful structure for care of these cases. The data thus far indicate that insulin pump therapy can be continued safely during the perioperative period.

AB - Background: An institutional policy was previously established for patients with diabetes on insulin pump therapy undergoing elective surgical procedures. Method: Electronic medical records were reviewed to assess documentation of insulin pump status and glucose monitoring during preoperative, intraoperative, and postanesthesia care unit (PACU) phases of care. Results: Twenty patients with insulin pumps underwent 23 procedures from March 1 to December 31, 2011. Mean (standard deviation) age was 58 (13) years, mean diabetes duration was 28 (17) years, and mean duration of insulin pump therapy was 7 (6) years. Nearly all cases (86%) during the preoperative phase had the presence of the device documented-an improvement over the 64% noted in data collected before the policy. Intraoperatively, 13 cases (61%) had the presence of the pump documented, which was higher than the 28% before implementation of the policy. However, documentation of pump status was found in only 38% in the PACU and was actually less than the 60% documented previously. Over 90% of cases had glucose checked in the preoperative area and the PACU, and only 60% had it checked intraoperatively, which was nearly identical to the percentages seen before policy implementation. No adverse events occurred when insulin pump therapy was continued. Conclusions: Although some processes still require improvement, preliminary data suggest that the policy for perioperative management of insulin pumps has provided useful structure for care of these cases. The data thus far indicate that insulin pump therapy can be continued safely during the perioperative period.

KW - Continuous subcutaneous insulin infusion

KW - Hospital

KW - Inpatient

KW - Insulin pumps

KW - Perioperative

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84875806109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875806109&partnerID=8YFLogxK

U2 - 10.1177/193229681200600504

DO - 10.1177/193229681200600504

M3 - Article

C2 - 23063026

AN - SCOPUS:84875806109

VL - 6

SP - 1016

EP - 1021

JO - Journal of diabetes science and technology

JF - Journal of diabetes science and technology

SN - 1932-2968

IS - 5

ER -